Price
CHART BY
Frequently asked questions
What is the Earnings Per Share (EPS) for THC?
THC's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -0.016. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for THC's stock?
Currently, 1 analysts cover THC's stock, with a consensus target price of $0.143. Analyst ratings provide insights into the stock's expected performance.
What is THC's revenue over the trailing twelve months?
Over the trailing twelve months, THC reported a revenue of $2.04M.
What is the EBITDA for THC?
THC's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$838.64K. EBITDA measures the company's overall financial performance.
What is the free cash flow of THC?
THC has a free cash flow of -$342.47K. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does THC have, and what sector and industry does it belong to?
THC employs approximately 35 people. It operates in the Consumer Staples sector, specifically within the Agricultural Commodities/Milling industry.
Financials
- EPS (TTM)
- -0.016
- Revenue (TTM)
- $2.04M
- EBITDA (TTM)
- -$838.64K
- Free Cashflow (TTM)
- -$342.47K
Analyst Ratings
The price target is $0.143 and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
THC BioMed International Ltd. engages in the research, development and cultivation of medical cannabis. It offers horticulture training, record keeping and documenting, research studies and analytical services. The company was founded on February 2, 1982 and is headquartered in Kelowna, Canada.
- Employees
- 35
- Industries
- Agricultural Commodities/Milling
- Sector
- Consumer Staples
Identifier
- ISIN
- CA87243W1032
- Primary Ticker
- THC
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet